ISOVUE 300 is a Intravascular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bipso Gmbh. The primary component is Iopamidol.
Product ID | 76381-315_31076157-8a24-15d8-2f7d-343ddf017bff |
NDC | 76381-315 |
Product Type | Human Prescription Drug |
Proprietary Name | ISOVUE 300 |
Generic Name | Iopamidol |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVASCULAR |
Marketing Start Date | 1994-10-12 |
Marketing Category | NDA / NDA |
Application Number | NDA020327 |
Labeler Name | BIPSO GmbH |
Substance Name | IOPAMIDOL |
Active Ingredient Strength | 612 mg/mL |
Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1994-10-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Ingredient | Strength |
---|---|
IOPAMIDOL | 612 mg/mL |
SPL SET ID: | 4ec262e0-be4d-6f15-f36f-355b193c8374 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
76381-315 | ISOVUE 300 | ISOVUE 300 |
0270-1314 | ISOVUE | IOPAMIDOL |
0270-1315 | ISOVUE | IOPAMIDOL |
0270-1316 | ISOVUE | IOPAMIDOL |
0270-1317 | ISOVUE | IOPAMIDOL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ISOVUE 85423219 4243227 Dead/Cancelled |
Centrix, Inc. 2011-09-15 |
ISOVUE 75239760 2132582 Dead/Cancelled |
BRACCO DIAGNOSTICS, INC. 1997-02-07 |
ISOVUE 73299442 1237972 Live/Registered |
E. R. Squibb & Sons, Inc. 1981-02-25 |